loadpatents
Patent applications and USPTO patent grants for CHANGCHUN GENESCIENCE PHARMACEUTICAL CO., LTD..The latest application filed is for "humanized anti-a[beta] monoclonal antibody and application thereof".
Patent | Date |
---|---|
Humanized Anti-a[beta] Monoclonal Antibody And Application Thereof App 20220242936 - FENG; XIAO ;   et al. | 2022-08-04 |
Humanized Anti-a[beta] Monoclonal Antibody And Application Thereof App 20220242937 - FENG; XIAO ;   et al. | 2022-08-04 |
Anti-CD47 monoclonal antibody and use thereof App 20220089727 - FENG; Xiao ;   et al. | 2022-03-24 |
Antibody Fusion Protein, Preparation Method Therefor And Application Thereof App 20220073620 - FENG; Xiao ;   et al. | 2022-03-10 |
Bivalent Bispecific Antibody And Prepartion Method Thereof, Coding Gene, Host Cell And Composition App 20220073610 - FENG; Xiao ;   et al. | 2022-03-10 |
Anti-CD47 monoclonal antibody and use thereof Grant 11,155,632 - Feng , et al. October 26, 2 | 2021-10-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.